Clinical Trial

The Role of Biomarkers in the Occurrence and Development of Asthma

Recruiting
View on ClinicalTrials.gov →
Summary
To study the expression level of biomarkers such as GITRL in peripheral blood of children with asthma and analyze their correlation with the severity of asthma. To study the predictive value of biomarkers level for the occurrence and development of asthma. And to provide supplementary detection means and predictive indicators for the diagnosis of asthma and the severity of asthma.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-03-13.
Status change: Not Yet Recruiting → Recruiting 2023-07-05
Trial Details
NCT Number NCT05768399
Lead Sponsor Children's Hospital of Chongqing Medical University
Conditions Asthma in Children
Enrollment 2 participants
Start Date 2023-07-04
Primary Completion 2028-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-07-07